Internationally Renowned Botulinum Toxin Experts Join WizMedi Bio's New Botulinum Toxin Development Project

錯誤訊息

Notice：Undefined property: stdClass::$ds_changed 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 16 行)。
Notice：Undefined property: stdClass::$ss_search_api_url 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 20 行)。
Notice：Undefined property: stdClass::$tm_title 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 20 行)。
Notice：Undefined property: stdClass::$ds_changed 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 16 行)。
Notice：Undefined property: stdClass::$ss_search_api_url 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 20 行)。
Notice：Undefined property: stdClass::$tm_title 於 eval() (/var/www/7/modules/php/php.module(80) : eval()'d code 中的第 20 行)。

SEOUL, KOREA, April 26, 2024 (GLOBE NEWSWIRE) -- Dr. Eric A. Johnson and Professor Dirk Dressler, internationally renowned botulinum toxin experts, visited South Korea in March this year to join WizMedi Bio's new botulinum toxin development project.

Metadata

Provider:

GlobeNewswire, Inc.

Retrieved on:

星期五, 四月 26, 2024

Information

Tags:

Spasticity, Bacteriology, WARF, University, Dystonia, Publication, Partnership, Research, AB toxin, Hannover Medical School, Movement disorder, Professional, Acquisition, Jan Vansina, Hyperhidrosis, Migraine, Wisconsin Alumni Research Foundation, Canning

Geotags:

SEOUL, KOREA, KR, GERMANY

⚠ partially generated by AI ↴

摘要

Key Points:

SEOUL, KOREA, April 26, 2024 (GLOBE NEWSWIRE) -- Dr. Eric A. Johnson and Professor Dirk Dressler, internationally renowned botulinum toxin experts, visited South Korea in March this year to join WizMedi Bio's new botulinum toxin development project.
The long-standing collaboration between Dr. Johnson and Professor Dressler has shaped the global botulinum toxin landscape over the past decades.
Dr. Johnson, a retired professor of bacteriology at the University of Wisconsin-Madison in the US, has dedicated over four decades to botulinum toxin research, authoring over 200 publications and founded 3 botulinum toxin companies.
Having introduced most of the major botulinum toxin drugs to the international markets, he is a highly sought-after consultant to the botulinum toxin industry.

SEOUL, KOREA, April 26, 2024 (GLOBE NEWSWIRE) -- Dr. Eric A. Johnson and Professor Dirk Dressler, internationally renowned botulinum toxin experts, visited South Korea in March this year to join WizMedi Bio's new botulinum toxin development project. Their involvement is expected to profoundly boost product development and registration processes.

The long-standing collaboration between Dr. Johnson and Professor Dressler has shaped the global botulinum toxin landscape over the past decades. Dr. Johnson, a retired professor of bacteriology at the University of Wisconsin-Madison in the US, has dedicated over four decades to botulinum toxin research, authoring over 200 publications and founded 3 botulinum toxin companies. His prominent contributions led to the development of the first botulinum toxin drug.

Professor Dressler, the head of the Movement Disorders Section at Hannover Medical School in Germany, has been at the forefront of both translational botulinum toxin research and the development of all significant clinical applications, including dystonia, spasticity, migraine, hyperhidrosis, and aesthetic indications. Having introduced most of the major botulinum toxin drugs to the international markets, he is a highly sought-after consultant to the botulinum toxin industry.

WizMedi Bio recently announced the acquisition of the exclusive rights to the newly developed and patented botulinum toxin type A6 strain from the Wisconsin Alumni Research Foundation(WARF), a subsidiary of the University of Wisconsin.